HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A O Shpakov Selected Research

Melanocortin Receptors (Melanocortin Receptor)

1/2015[THE EFFECTS OF LONG-TERM METFORMIN TREATMENT ON THE ACTIVITY OF ADENYLYL CYCLASE SYSTEM AND NO-SYNTHASES IN THE BRAIN AND THE MYOCARDIUM OF RATS WITH OBESITY].
1/2012[The brain peptidergic signaling systems in diabetes mellitus].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A O Shpakov Research Topics

Disease

21Type 2 Diabetes Mellitus (MODY)
02/2022 - 10/2008
21Diabetes Mellitus
05/2021 - 12/2006
20Insulin Resistance
12/2022 - 01/2012
10Obesity
12/2022 - 09/2014
10Hyperglycemia
12/2022 - 11/2007
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2019 - 01/2010
8Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2022 - 05/2015
7Body Weight (Weight, Body)
12/2022 - 01/2014
7Experimental Diabetes Mellitus
11/2019 - 01/2005
5Glucose Intolerance
08/2022 - 01/2014
4Cognitive Dysfunction
11/2019 - 11/2015
3Dyslipidemias (Dyslipidemia)
08/2022 - 11/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 10/2015
3Starvation
07/2014 - 04/2007
2Hyperthyroidism
04/2022 - 03/2020
2Neoplasms (Cancer)
03/2020 - 01/2001
2Hyperinsulinism (Hyperinsulinemia)
01/2019 - 01/2014
2Autoimmune Diseases (Autoimmune Disease)
07/2016 - 01/2015
2Peripheral Nervous System Diseases (PNS Diseases)
02/2016 - 02/2013
2Ganglion Cysts (Ganglion)
04/2005 - 04/2005
1Ovarian Hyperstimulation Syndrome
12/2022
1Hypothyroidism
04/2022
1Graves Disease (Basedow Disease)
03/2020
1Weight Loss (Weight Reduction)
11/2019
1Feeding and Eating Disorders (Eating Disorder)
11/2019
1Lactic Acidosis
01/2019
1Ischemia
01/2019
1Brain Ischemia (Cerebral Ischemia)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2017
1Hyperhomocysteinemia
01/2017

Drug/Important Bio-Agent (IBA)

33Insulin (Novolin)FDA Link
12/2022 - 04/2005
24Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2016 - 01/2005
13Glucose (Dextrose)FDA LinkGeneric
12/2022 - 11/2007
12Streptozocin (Streptozotocin)FDA Link
02/2022 - 11/2007
11Hormones (Hormone)IBA
09/2014 - 12/2006
8Metformin (Glucophage)FDA LinkGeneric
02/2022 - 01/2015
7Proteins (Proteins, Gene)FDA Link
09/2014 - 01/2001
6MelanocortinsIBA
01/2019 - 01/2016
6Serotonin (5 Hydroxytryptamine)IBA
01/2018 - 04/2005
6Peptides (Polypeptides)IBA
01/2017 - 04/2005
5LeptinIBA
12/2022 - 01/2014
5CarbohydratesIBA
11/2019 - 01/2012
5C-PeptideIBA
07/2019 - 01/2013
5GTP-Binding Proteins (G-Protein)IBA
11/2007 - 01/2001
4Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
04/2022 - 11/2015
4RelaxinIBA
05/2020 - 04/2007
4EnzymesIBA
11/2015 - 01/2007
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2014 - 11/2007
4Biogenic Amines (Biogenic Amine)IBA
01/2012 - 01/2005
3Thyrotropin Receptors (Thyrotropin Receptor)IBA
04/2022 - 03/2020
3Phosphotransferases (Kinase)IBA
05/2020 - 01/2016
3Isoproterenol (Isoprenaline)FDA LinkGeneric
05/2015 - 04/2007
3Insulin-Like Growth Factor I (IGF-1)IBA
01/2014 - 04/2005
2Leptin ReceptorsIBA
12/2022 - 01/2016
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2022 - 01/2016
2Thyroid HormonesIBA
08/2022 - 11/2015
2Thyroxine (Levothyroxine)FDA LinkGeneric
08/2022 - 11/2015
2Testosterone (Sustanon)FDA Link
08/2022 - 07/2013
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
02/2022 - 11/2010
2LH Receptors (LH Receptor)IBA
02/2022 - 05/2021
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019 - 01/2012
2Dopamine (Intropin)FDA LinkGeneric
01/2018 - 03/2015
2CholesterolIBA
06/2017 - 01/2015
2Triglycerides (Triacylglycerol)IBA
06/2017 - 01/2014
2Vasodilator Agents (Vasodilators)IBA
01/2017 - 11/2015
2Dopamine Receptors (Dopamine Receptor)IBA
01/2017 - 01/2014
2AntibodiesIBA
07/2016 - 01/2015
2EpitopesIBA
07/2016 - 01/2015
2Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
05/2015 - 04/2005
2Adrenergic Agents (Adrenergic Drugs)IBA
05/2015 - 01/2012
2Melanocortin Receptors (Melanocortin Receptor)IBA
01/2015 - 01/2012
2ColforsinIBA
09/2014 - 11/2007
2Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
11/2010 - 12/2006
2Peptide Hormones (Polypeptide Hormones)IBA
11/2010 - 04/2007
2Guanosine Triphosphate (GTP)IBA
04/2007 - 01/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2022
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
08/2022
1LipidsIBA
08/2022
1GonadotropinsIBA
02/2022
1Bromocriptine (Parlodel)FDA LinkGeneric
01/2022
1PyrimidinesIBA
05/2021
1pyridineIBA
05/2021
1pyrimidineIBA
05/2021
1AMP-Activated Protein KinasesIBA
05/2020
1GangliosidesIBA
01/2020
1Protein Tyrosine PhosphatasesIBA
01/2019
1Transaminases (Aminotransferases)IBA
01/2019
1Lactic Acid (Lactate)FDA LinkGeneric
01/2019
1Glucagon-Like Peptide-1 ReceptorIBA
01/2019
1GhrelinIBA
01/2019
1Adenosine Triphosphatases (ATPase)IBA
01/2019
1Endothelin-1 (Endothelin 1)IBA
01/2017

Therapy/Procedure

6Therapeutics
07/2020 - 01/2012
3Intranasal Administration
01/2020 - 09/2011
1Gastrectomy
01/2019
1Bariatric Surgery
01/2019
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2019
1Oral Administration
01/2019